Company | Cost to borrow (% year) | Shares available | Country |
---|---|---|---|
Novartis NVS | 0.4081% | 0.65 M | ๐จ๐ญ Switzerland |
Pfizer PFE | 0.4186% | 10 M | ๐บ๐ธ USA |
AstraZeneca AZN | 0.25% | 2.3 M | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | 0.25% | 2 M | ๐ฌ๐ง UK |
Sarepta Therapeutics
SRPT | 0.4081% | 0.6 M | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | 0.25% | 0.2 M | ๐บ๐ธ USA |
Agenus
AGEN | 1.0684% | 0.1 M | ๐บ๐ธ USA |
NanoViricides NNVC | 13.6277% | 0.25 M | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | 0.3968% | 2.3 M | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | 0.855% | 0.75 M | ๐บ๐ธ USA |